Singapore Medical Group has its heart set on regional growth
The group aims to strengthen its foothold abroad, albeit with cautious optimism, especially in Australia, Vietnam and Indonesia.
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.
Even as it continues to grow its domestic business across the Republic's heartlands, the Catalist-listed company is hungry for further expansion and new ventures in the Asia-Pacific.
"We're one of the few Singapore healthcare companies that have been actively investing and growing our overseas footprint. From that standpoint, we're extremely unique," says Beng Teck Liang, SMG's chief executive officer and executive director.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
